Camtek (CAMT) Q4 2025 earnings review
Record Year Hits a Speed Bump in Q1
Camtek delivered a solid finish to 2025 with record Q4 revenue of $128.1M (+9% YoY) and full-year revenue nearing $0.5B. Profitability remained robust with non-GAAP gross margins expanding to 51.1%. However, the immediate outlook dampens the 'AI super-cycle' narrative: Q1 2026 guidance of ~$120M implies a 6% sequential decline and flat YoY growth. While management promises a 'double-digit growth year' for 2026 weighted towards H2, the short-term trajectory is reversing.
🐂 Bull Case
The company remains at the epicenter of the AI hardware build-out. 45-50% of revenue is tied to High-Performance Computing (HPC), with specific demand for HBM and Chiplet applications necessitating more inspection layers.
Cash and equivalents ballooned to $851M (up from $449M YoY), primarily due to a convertible notes offering. This massive war chest ($19/share) provides flexibility for M&A or navigating volatility.
🐻 Bear Case
The 'Double-Digit Growth' promise for 2026 relies entirely on a significant ramp in H2. With Q1 guiding down sequentially, any delay in customer capacity expansion (HBM4 or otherwise) puts the full-year target at risk.
YoY revenue growth has compressed from ~34% in 25Q1 to 9% in 25Q4, and is guided to ~1% in 26Q1. The hyper-growth phase appears to be normalizing despite the AI narrative.
⚖️ Verdict: ⚪
Neutral. The long-term AI inspection thesis remains intact, and margins are healthy. However, the Q1 guidance indicates a distinct air pocket in demand. Investors must trust management's visibility into a H2 2026 acceleration to justify the current valuation.
Key Themes
Immediate Guidance Deceleration
Management guided Q1 2026 revenue to ~$120M. This is a sequential decline from $128.1M in Q4 and represents negligible growth vs 25Q1 ($118.7M). This contradicts the momentum implied by 'aggressive expansion' comments, suggesting timing issues or digestion of previous capacity additions by customers.
Product Mix Lifting Margins
Non-GAAP Gross Margin reached 51.1% in Q4 (up from 50.6% YoY) and 51.6% for FY25. This is driven by the shift to higher-ASP systems like the Eagle G5 and Hawk, which are essential for inspecting fine-pitch (<10 micron) bumps in advanced packaging.
Healthy Cash Generation
Operating cash flow was strong at $61.2M in Q4, representing 48% of revenue. However, the divergence between GAAP Net Income ($35.9M) and Non-GAAP Net Income ($40.7M) remains notable, largely due to stock-based compensation and acquisition-related expenses.
Geopolitical & Supply Chain Friction
While shipping costs normalized after the Q2 spike (Iran conflict), the company remains sensitive to geopolitical risks given its Israel HQ and 90% revenue exposure to Asia (specifically China/Taiwan). High inventory levels ($112M) are being maintained to mitigate supply chain risks.
GAAP Profitability Compression
While Non-GAAP income grew 15% in FY25, GAAP Net Income fell 57% YoY ($50.7M vs $118.5M). This was heavily impacted by a $100.9M expense related to the extinguishment of convertible notes, a significant one-time hit to the bottom line.
Other KPIs
Stable. Up 16% YoY. The company essentially hit the $500M milestone annualized run-rate in H2, but FY total fell just shy of the half-billion mark.
Improved. Trade accounts receivable dropped to $90.8M from $99.4M YoY despite higher revenues, indicating strong collections and no channel stuffing issues often seen at cycle peaks.
Stable. Virtually flat YoY ($111.2M in 2024). This is a positive sign of disciplined working capital management, avoiding the inventory bloat that plagues other semi-cap equipment peers during downturns.
Guidance
Decelerating/Reversing. This represents a ~6% sequential decline and is roughly flat (+1%) YoY compared to 25Q1 ($118.7M). Management attributes growth later in the year to H2 weighting.
Accelerating (implied). Given the soft Q1 start (~$120M), achieving just 10% growth (target ~$545M) would require the remaining three quarters to average ~$142M each. This implies a very steep ramp in H2.
Key Questions
Q1 Weakness Specifics
Q1 guidance of $120M is a sequential step down and flat YoY. Is this driven by specific customer pushouts, seasonal softness, or a pause in HBM capacity additions before the HBM4 transition?
Visibility on H2 Ramp
To hit 'double-digit growth' after a soft Q1, H2 needs to be significantly stronger. What percentage of that H2 ramp is currently in the firm backlog versus pipeline/expectations?
Capital Allocation Plans
You are sitting on $851M in cash and securities. With the stock up significantly, what is the plan for this capital? Are there active M&A targets in metrology or inspection to complement the FRT acquisition?